Elenitoba-Johnson KS - Search Results

1

Multiple interactions recruit MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesis.

Milne TA, Kim J, Wang GG, Stadler SC, Basrur V, Whitcomb SJ, Wang Z, Ruthenburg AJ, Elenitoba-Johnson KS, Roeder RG, Allis CD. Milne TA, et al. Mol Cell. 2010 Jun 25;38(6):853-63. doi: 10.1016/j.molcel.2010.05.011. Epub 2010 Jun 10. Mol Cell. 2010. PMID: 20541448 Free PMC article.

2

Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.

Biswas D, Milne TA, Basrur V, Kim J, Elenitoba-Johnson KS, Allis CD, Roeder RG. Biswas D, et al. Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15751-6. doi: 10.1073/pnas.1111498108. Epub 2011 Sep 6. Proc Natl Acad Sci U S A. 2011. PMID: 21896721 Free PMC article.

3

The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis.

Muntean AG, Tan J, Sitwala K, Huang Y, Bronstein J, Connelly JA, Basrur V, Elenitoba-Johnson KS, Hess JL. Muntean AG, et al. Cancer Cell. 2010 Jun 15;17(6):609-21. doi: 10.1016/j.ccr.2010.04.012. Cancer Cell. 2010. PMID: 20541477 Free PMC article.

4

KDM2A represses transcription of centromeric satellite repeats and maintains the heterochromatic state.

Frescas D, Guardavaccaro D, Kuchay SM, Kato H, Poleshko A, Basrur V, Elenitoba-Johnson KS, Katz RA, Pagano M. Frescas D, et al. Cell Cycle. 2008 Nov 15;7(22):3539-47. doi: 10.4161/cc.7.22.7062. Epub 2008 Nov 24. Cell Cycle. 2008. PMID: 19001877 Free PMC article.

5

Fusion peptides from oncogenic chimeric proteins as putative specific biomarkers of cancer.

Conlon KP, Basrur V, Rolland D, Wolfe T, Nesvizhskii AI, MacCoss MJ, Lim MS, Elenitoba-Johnson KS. Conlon KP, et al. Mol Cell Proteomics. 2013 Oct;12(10):2714-23. doi: 10.1074/mcp.M113.029926. Epub 2013 Jul 8. Mol Cell Proteomics. 2013. PMID: 23836920 Free PMC article.

6

MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.

Monroe SC, Jo SY, Sanders DS, Basrur V, Elenitoba-Johnson KS, Slany RK, Hess JL. Monroe SC, et al. Exp Hematol. 2011 Jan;39(1):77-86.e1-5. doi: 10.1016/j.exphem.2010.09.003. Epub 2010 Sep 18. Exp Hematol. 2011. PMID: 20854876 Free PMC article.

7

Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma.

Busino L, Millman SE, Scotto L, Kyratsous CA, Basrur V, O'Connor O, Hoffmann A, Elenitoba-Johnson KS, Pagano M. Busino L, et al. Nat Cell Biol. 2012 Mar 4;14(4):375-85. doi: 10.1038/ncb2463. Nat Cell Biol. 2012. PMID: 22388891 Free PMC article.

8

Fbxo45-mediated degradation of the tumor-suppressor Par-4 regulates cancer cell survival.

Chen X, Sahasrabuddhe AA, Szankasi P, Chung F, Basrur V, Rangnekar VM, Pagano M, Lim MS, Elenitoba-Johnson KS. Chen X, et al. Cell Death Differ. 2014 Oct;21(10):1535-45. doi: 10.1038/cdd.2014.92. Epub 2014 Jul 4. Cell Death Differ. 2014. PMID: 24992930 Free PMC article.

9

Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative Burkitt lymphoma.

El-Mallawany NK, Day N, Ayello J, Van de Ven C, Conlon K, Fermin D, Basrur V, Elenitoba-Johnson K, Lim M, Cairo MS. El-Mallawany NK, et al. Eur J Cancer. 2015 Jan;51(1):92-100. doi: 10.1016/j.ejca.2014.10.017. Epub 2014 Nov 6. Eur J Cancer. 2015. PMID: 25466511

10

FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells.

Saffie R, Zhou N, Rolland D, Önder Ö, Basrur V, Campbell S, Wellen KE, Elenitoba-Johnson KSJ, Capell BC, Busino L. Saffie R, et al. Cancer Res. 2020 Jun 15;80(12):2498-2511. doi: 10.1158/0008-5472.CAN-19-2247. Epub 2020 Apr 29. Cancer Res. 2020. PMID: 32350066 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters